Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091934 · ClinicalTrials.gov registry record · NA
Wavefront-guided PRK vs Wavefront-optimized PRK
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02091934: Completed NA study, sponsored by Stanford University.
NCT02091934 is a NA study that has completed, run by Stanford University. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02091934, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the results of PRKK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism
Interventions
- PROCEDURE Wavefront-guided PRK
- PROCEDURE Wavefront-optimized PRK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2009-04-01 |
| Est. Completion | 2012-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02091934
The ClinicalTrials.gov registry entry for NCT02091934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wavefront-guided PRK is the first listed.
NCT02091934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02091934 about?
NCT02091934 is a clinical study titled "Wavefront-guided PRK vs Wavefront-optimized PRK". The purpose of the study is to compare the results of PRKK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism
What is the current status of trial NCT02091934?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2009-04-01. Estimated completion is 2012-03-31.
What interventions are being tested in trial NCT02091934?
The interventions under investigation include: Wavefront-guided PRK (PROCEDURE), Wavefront-optimized PRK (PROCEDURE).
Who is sponsoring clinical trial NCT02091934?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.